Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $300.00 (Oppenheimer)
- Lowest: $157.00 (HSBC)
- Average: $222.07
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$222.07 (+7.8%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
Avg. $ Target:
$222.07 (+7.8%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Truist Securities | Danielle Brill | Upgrade | Buy (Hold) |
235.00 (N/A) |
199.15 (205.99) |
3.43% | Details |
| 6/8/2026 | Needham » Updated 6/29/2026 |
Ami Fadia | Upgrade | Buy (Hold) |
256.00 (255.00) |
195.34 (205.99) |
5.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
